Invention Grant
- Patent Title: Anti-TNFRSF9 antibodies and uses thereof
-
Application No.: US17200021Application Date: 2021-03-12
-
Publication No.: US11292849B2Publication Date: 2022-04-05
- Inventor: Yi Yang , Jingshu Xie , Chunyan Dong , Fang Yang , Chengyuan Lu , Yuelei Shen , Jian Ni , Yanan Guo , Yunyun Chen
- Applicant: Eucure (Beijing) Biopharma Co., Ltd
- Applicant Address: CN Beijing
- Assignee: Eucure (Beijing) Biopharma Co., Ltd
- Current Assignee: Eucure (Beijing) Biopharma Co., Ltd
- Current Assignee Address: CN Beijing
- Agency: Fish & Richardson P.C.
- Priority: WOPCT/CN2018/105162 20180912
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68
Abstract:
This disclosure relates to anti-TNFRSF9 (tumor necrosis factor receptor superfamily member 9) antibodies, antigen-binding fragments, and the uses thereof.
Public/Granted literature
- US20210206867A1 ANTI-TNFRSF9 ANTIBODIES AND USES THEREOF Public/Granted day:2021-07-08
Information query
